Atrial Fibrillation

Apple Watch could be used to detect arrhythmias other than AFib, study shows

A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.

FDA to review data on stroke-prevention implants after study finds more adverse events in women

A study published in August found that women experienced more adverse events from Boston Scientific’s Watchman implant than men. The FDA said it plans to take a closer look at data for these stroke-prevention implants, but still says the benefits outweigh the risks. 

AI could be used to guide drug therapy for heart failure

UK researchers have used artificial intelligence (AI) to develop a way to identify patients with heart failure who would benefit from treatment with beta blockers, by interrogating data from nine landmark clinical trials. The study applied machine learning to trial data involving 15,659 patients who were being treated for heart failure with reduced ejection fraction …

AI could be used to guide drug therapy for heart failure Read More »

Real-world study suggest AI may improve atrial fibrillation screening

An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost …

Real-world study suggest AI may improve atrial fibrillation screening Read More »

Abbott Reports Head-to-Head Data for Amplatzer Amulet Against Boston Scientific’s Watchman Device to Treat Atrial Fibrillation #ESC2021

Shots: The head-to-head Amulet IDE study compares Amplatzer Amulet Left Atrial Appendage (LAA) Occluder with the Watchman device to treat patients with AFib at an increased risk of stroke The study demonstrated superiority for the 1EPs of LAA (98.9% vs 96.8%) and was non-inferior for the co-primary safety & effectiveness endpoints Abbott’s Amulet Occluder with …

Abbott Reports Head-to-Head Data for Amplatzer Amulet Against Boston Scientific’s Watchman Device to Treat Atrial Fibrillation #ESC2021 Read More »

MedLumics raises €18 million for atrial fibrillation device

MedLumics has raised another €18 million (around $22 million) to fund clinical trials of its optically-guided imaging system used to guide a surgical procedure for atrial fibrillation (AF) – a serious heart condition that causes an irregular heartbeat.  The Spanish biotech says the latest round – which comes after a $3.8 million first round in …

MedLumics raises €18 million for atrial fibrillation device Read More »

iRhythm digital heart monitoring service backed by NICE

A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies. In new guidance, the health technology assessment (HTA) agency has recommended iRhythm’s Zio XT service for detecting abnormal heart rhythms – provided NHS organisations that deploy it collect evidence of its …

iRhythm digital heart monitoring service backed by NICE Read More »

AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms

What You Should Know: – AliveCor announced they received FDA clearance of new algorithms for use with their personal EKG devices, KardiaMobile and KardiaMobile 6L. These additional determinations will be available via a software upgrade for the Kardia devices in 2021. – The additional FDA-cleared algorithms double the number of heart rhythm disturbances that AliveCor’s …

AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms Read More »

Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam

What You Should Know: – Cardiopulmonary digital health company Eko raises $65M in Series C funding to close the gap between virtual and in-person heart and lung care. – The latest round of funding will enable Eko to expand in-clinic use of its platform of telehealth and AI algorithms for disease screening and to launch …

Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam Read More »

AI Leads Way to Less False Positives on Remote Cardiac Monitoring Devices, Improved Results

What You Should Know: – Cardiac patients and their cardiologists are experiencing a high number of false positives with remote patient monitoring devices as a result of signal artifact providing inaccurate data, which can lead to many complications—other than medical, such as unnecessary tests and increased medical costs. – Ambulatory cardiac monitoring provider InfoBionic has …

AI Leads Way to Less False Positives on Remote Cardiac Monitoring Devices, Improved Results Read More »

RHYTHM AI cleared for large trial of atrial fibrillation mapping tool

UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need for medication. Antiarrhythmic drugs are standard therapy but they often only work for around 18 months, after which time a catheter ablation procedure is …

RHYTHM AI cleared for large trial of atrial fibrillation mapping tool Read More »

AstraZeneca, Eko Collaborate to Advance Innovation Around Heart Failure

What You Should Know: – Eko today announced a global collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart failure.  – Through the collaboration, AstraZeneca and Eko will explore accelerating the development of Eko algorithms, enhancing clinical trials with Eko technology, and potentially building …

AstraZeneca, Eko Collaborate to Advance Innovation Around Heart Failure Read More »

Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms

What You Should Know: – The National Institutes of Health (NIH) has granted next-generation cardiac AI company Eko an award totaling $2.7 million to support continued collaborative work with Northwestern Medicine Bluhm Cardiovascular Institute – The grant will focus on validating algorithms and help more accurately screen for heart murmurs and valvular heart disease during …

Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms Read More »